Intracerebral haemorrhage: An often neglected medical emergency

Internal and Emergency Medicine

Volumn 2, Issue 1, 2007, Pages 38-45

  Marietta, M ^a   Pedrazzi, P ^a   Girardis, M ^b   Torelli, G ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Antiplatelet drugs; Emergency medicine; Intracerebral haemorrhage; Oral anticoagulants; Recombinant activated factor VII

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; BRAIN HEMORRHAGE; CHEMICALLY INDUCED DISORDER; EMERGENCY TREATMENT; HUMAN; PATHOPHYSIOLOGY;

ANTICOAGULANTS; CEREBRAL HEMORRHAGE; EMERGENCY TREATMENT; HUMANS;

EID: 34249874587     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-007-0009-y     Document Type: Article

References (75)

1. Sacco RL, Mayer SA (1994) Epidemiology of intracerebral hemorrhage. In: Feldmann E (ed) Intracerebral hemorrhage. Futura Publishing Co, New York, pp 3-23
2. Taylor TN, Davis PH, Torner JC et al (1996) Lifetime cost of stroke in the United States. Stroke 27:1459-1466
3. Broderick JP, Adams HP Jr, Barsan W et al (1999) Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30:905-915
4. Gebel JM, Broderick JP (2000) Intracerebral hemorrhage. Neurol Clin 18:419-438
5. Qureshi AI, Tuhrim S, Broderick JP et al (2001) Spontaneous intracerebral hemorrhage. N Engl J Med 344:1450-1460
6. Hart RG, Tonarelli SB, Pearce LA (2005) Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 36:1588-1593
7. Brott T, Broderick J, Kothari R et al (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1-5
8. Fujii Y, Tanaka R, Takeuchi S (1994) Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 80:51-57
9. Kazui S, Naritomi H, Yamamoto H et al (1996) Enlargement of spontaneous intracerebral hemorrhage: incidence and time course. Stroke 27:1783-1787
10. Hemphill JC III, Bonovich DC, Besmertis L et al (2001) The ICH Score. A simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891-897
11. Mayer SA (2003) Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 34:224-229
12. Lee KR, Colon GP, Betz AL et al (1996) Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 84:91-96
13. Lee KR, Kawai N, Kim S et al (1997) Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 86:272-278
14. Xi G, Keep RF, Hoff JT (2002) Pathophysiology of brain edema formation. Neurosurg Clin N Am 13:371-383
15. Franke CL, de Jonge J, van Swieten JC et al (1990) Intracerebral hematomas during anticoagulant treatment. Stroke 21:726-730
16. Hart RG, Boop BS, Anderson DC (1995) Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26:1471-1477
17. Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inceptioncohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 348:423-428
18. Nicolini A, Ghirarduzzi A, Iorio A et al (2002) Intracranial bleeding: epidemiology and relationships with antithrombotic treatment in 241 cerebral hemorrhages in Reggio Emilia. Haematologica 87:948-956
19. Steiner T, Rosand J, Diringer M (2006) Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions. Stroke 37:256-262
20. Hylek EM, Go AS, Chang Y et al (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019-1026
21. Fang MC, Chang Y, Hylek EM et al (2004) Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 141:745-752
22. Rosand J, Eckman MH, Knudsen KA et al (2004) The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164:880-884
23. _ (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449-1457
24. Stroke Prevention in Atrial Fibrillation Investigators (1996) Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 156:409-416
25. Flibotte JJ, Hagan N, O'Donnell J et al (2004) Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63:1059-1064
26. Diener H-C, Bogousslavsky J, Brass LM et al (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double blind, placebo-controlled trial. Lancet 364:331-337
27. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without St-segment elevation. N Engl J Med 345:494-502
28. Saloheimo P, Ahonen M, Juvela S et al (2006) Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke 37:129-133
29. Nilsson OG, Lindgren A, Brandt L, Säveland H (2002) Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 97:531-536
30. Toyoda K, Okada Y, Minematsu K et al (2005) Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology 65:1000-1004
31. Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T for the Arbeitsgruppe Schlaganfall Hessen (2006) Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke 37:2165-2167
32. Howard PA, Ellerbeck EF, Engelman KK, Patterson KL (2002) The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation. Pharmacoepidemiol Drug Saf 11:569-576
33. Hart RG, Benavente O, Pearce LA (1999) Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc Dis 9:215-217
34. Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF (2004) Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 35:2362-2367
35. Berwaerts J, Webster J (2000) Analysis of risk factors involved in oral-anticoagulant-related intracranial hemorrhages. Q J Med 93:513-521
36. Fang MC, Chang Y, Hylek EM et al (2004) Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 141:745-752
37. Hemphill JC III (2006) Treating warfarin-related intracerebral hemorrhage. Is fresh-frozen plasma enough? Stroke 37:6-7
38. Mayer SA, Rincon F (2005) Treatment of intracerebral haemorrhage. Lancet Neurol 4:662-672
39. Qureshi AI, Bliwise DL, Bliwise NG et al (1999) Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral haemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 27:480-485
40. Willmot M, Leonardi-Bee J, Bath PMW (2004) High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 43:18-24
41. Jauch EC, Lindsell CJ, Adeoye O et al (2006) Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 37:2061-2065
42. Cottrell JE, Patel K, Turndorf H, Ransohoff J (1978) Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg 48:329-331
43. Poungvarin N, Bhoopat W, Viriyavejakul A et al (1987) Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 316:1229-1233
44. Yu YL, Kumana CR, Lauder IJ et al (1992) Treatment of acute cerebral hemorrhage with intravenous glycerol: a double-blind, placebo-controlled, randomised trial. Stroke 23:967-971
45. Italian Acute Stroke Study Group (1988) Haemodilution in acute stroke: results of the Italian haemodilution trial. Lancet 1:318-321
46. Mendelow AD, Gregson BA, Fernandes HM et al; STICH Investigators (2005) Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365:387-397
47. Franchini M, Zaffanello M, Veneri D (2005) Recombinant factor Vila. An update on its clinical use. Thromb Haemost 93:1027-1035
48. Abshire T, Kenet G (2004) Recombinant factor Vila: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors. J Thromb Haemost 2:899-909
49. Mayer SA, Brun NC, Begtrup K et al for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777-785
50. You H, Al-Shani R (2006) Haemostatic drug therapies for acute primary intracerebral haemorrhage. Cochrane Database Syst Rev 2006 Jul 19;3:CD005951
51. Juvela S, Kase CS (2006) Advances in intracerebral hemorrhage management. Stroke 37:301-304
52. Flaherty ML, Woo D, Haverbusch M et al (2005) Potential applicability of recombinant factor Vila for intracerebral hemorrhage. Stroke 36:2660-2664
53. Kleindorfer D, Kissela B, Schneider A et al (2004) Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 35:e27-e29
54. British Committee for Standards in Haematology (1998) Guidelines on oral anticoagulation: third edition. Br J Haematol 101:374-387
55. Scottish Intercollegiate Guidelines Network (1999) Antithrombotic therapy. SIGN Publication Number 36, March
56. Hanley JP (2004) Warfarin reversal. J Clin Pathol 57:1132-1139
57. Baker RI, Coughlin PB, Gallus AS et al (2004) Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thromb Haemost. Med J Aust 181:492-497
58. Ansell J, Hirsh J, Poller L et al (2004) The pharmacology and management of the vitamin K antagonists. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:2048-2338
59. O'Shaughnessy DF, Atterbury C, Bolton Maggs P et al (2004) Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126:11-28
60. Kohler M, Hellstern P, Lechler E et al (1998) Thromboembolic complications associated with the use of prothrombin complex and factor IX concentrates. Thromb Haemost 80:399-402
61. Makris M, Greaves M, Phillips WS et al (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 77:477-480
62. Boulis NM, Bobek MP, Schmaler A, Hoff JT (1999) Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45:1113-1118
63. Huttner HB, Schellinger PD, Hartmann M et al (2006) Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy. Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke 37:1465-1470
64. Sjöblom L, Hardemark HG, Lindgren A et al (2001) Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study. Stroke 32:2567-2574
65. Sørensen B, Johansen P, Nielsen GL et al (2003) Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis 14:469-477
66. Freeman WD, Brott TG, Barrett KM et al (2004) Recombinant factor Vila for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc 79:1495-1500
67. Baldi G, Altomonte F, Altomonte M et al (2006) Intracranial haemorrhage in patients on antithrombotics: clinical presentation and determinants of outcome in a prospective multicentric study in Italian emergency departments. Cerebrovasc Dis 22:286-293
68. Goldstein JN, Thomas SH, Frontiero V et al (2006) Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage. Stroke 37:151-155
69. Bailey RD, Hart RG, Benavente O, Pearce LA (2001) Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56:773-777
70. Rosand J, Hylek EM, O'Donnell HC, Greenberg SM (2000) Warfarin associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55:947-951
71. Eckman MH, Rosand J, Knudsen KA et al (2003) Can patients be anticoagulated after intracerebral hemorrhage?: A decision analysis. Stroke 34:1710-1716
72. O'Donnell HC, Rosand J, Knudsen KA et al (2000) Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342:240-245
73. Aithal GP, Day CP, Kesteven PJ, Daly AK (1999) Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet 353:717-719
74. Higashi MK, Veenstra DL, Kondo LM et al (2002) Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA 287:1690-1698
75. Chapman N, Huxley R, Anderson C et al (2004) Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history. The PROGRESS Trial. Stroke 35:116-121